Killer Immunoglobulin‐like Receptor and Human Leukocyte Antigen Expression as Immunodiagnostic Parameters for Pelvic Endometriosis
article
OA: closed
CC0
⤵ 35 in-corpus citations
AI-generated summary
This study found increased CD158a expression on NK cells and decreased HLA expression on macrophages in women with endometriosis, suggesting impaired immune function.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: We investigated host immunologic responses to endometriosis by comparing immune cell surface antigens in peripheral blood (PB) and peritoneal fluid (PF) from women with endometriosis with those in PB and PF from other patients. METHOD OF STUDY: Japanese women with endometriosis (n = 56) were compared with controls with other laparoscopic diagnoses (n = 68). PB and PF were collected at the time of laparoscopy for flow cytometry. RESULTS: No significant difference in phenotypic parameters of T cells (CD3, CD4, and CD8), B cells (CD19), natural killer (NK) cells (CD56), or monocytes/macrophages (CD14) was seen between women with and without endometriosis. However, increased killer immunoglobulin-like receptor (CD158a) expression by NK cells and decreased human leukocyte antigen (HLA)-ABC and -DR expression by macrophages, all suggesting decreased functional activation were found in endometriosis. These markers showed significant association with endometriosis by odds ratio, logistic regression, and decision tree analyses. CONCLUSIONS: Increased CD158a(+) NK cells in PB and PF indicated decreased NK cell cytotoxicity in endometriosis, while decreased HLA expression on PF macrophages suggested impaired antigen presentation. Thus, aberrant immune responses by NK cells and macrophages may represent risk factors for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Aberrant expression of intercellular adhesion molecule-1 and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis via openalex
- Decreased Natural Killer Cell Activity in Women with Endometriosis via openalex
- Human leukocyte antigen expression by peritoneal macrophages from women with pelvic endometriosis is depressed but coordinated with costimulatory molecule expression via openalex
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
- Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis via openalex
- In vitro lymphocyte activity in women with endometriosis—an altered immune response? via openalex
- Killer Inhibitory Receptor CD158a Overexpression Among Natural Killer Cells in Women With Endometriosis is Undiminished by Laparoscopic Surgery and Gonadotropin Releasing Hormone Agonist Treatment* via openalex
- Modern concepts of endometriosis. Classification and its consequences for therapy. via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Production of Interleukins 1β, 6 and 8 and Tumor Necrosis Factor Alpha in Separated and Cultured Endometrial and Endometriotic Stromal and Epithelial Cells via openalex
- W2135526902 via openalex
- W2142285406 via openalex
- W2149706766 via openalex
- W2417327597 via openalex
- W11141567 via openalex
- W4236137412 via openalex
- W141728048 via openalex
- W1539488492 via openalex
- W2072832406 via openalex
- W2094706293 via openalex
- W2098130458 via openalex
- W2106419126 via openalex
- W2112615118 via openalex
- W2116364705 via openalex
- W2122739582 via openalex
Cited by (35)
- Changes in the number and activity of natural killer cells and its clinical association with endometriosis: systematic review and meta-analysis 2024
- The deviations of CD4 + T cells during peripheral blood and peritoneal fluid of endometriosis: a systematic review and meta-analysis 2023
- The effects of Rituximab on experimental endometriosis model in rats 2023
- CSF-1-induced DC-SIGN+ macrophages are present in the ovarian endometriosis 2022
- Peritoneal natural killer cell chemotaxis is decreased in women with pelvic endometriosis 2022
- Macrophages and Natural Killer Cells Characteristics in Variously Colored Endometriotic Lesions: A Cross-Sectional Analytic Study. 2022
- Endometrial galectin‐3 causes endometriosis by supporting eutopic endometrial cell survival and engraftment in the peritoneal cavity 2022
- Recombinant IL-2: clinical efficacy and pathogenetic rationale for use in external genital endometriosis 2021
- A History of Endometriosis Is Associated With Decreased Peripheral NK Cytotoxicity and Increased Infiltration of Uterine CD68+ Macrophages 2021
- CSF-1-Induced DC-SIGN+ Macrophages Work In The Ovarian Endometriosis 2021
- Functional changes of immune cells: signal of immune tolerance of the ectopic lesions in endometriosis? 2021
- Killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen-C (HLA-C) allorecognition patterns in women with endometriosis 2020
- Pelvic endometriosis and natural killer cell immunity 2020
- Toll-Like Receptor 2 Expression as a New Hallmark of Advanced Endometriosis 2020
- NK Cells as Potential Targets for Immunotherapy in Endometriosis 2019
- IL15 promotes growth and invasion of endometrial stromal cells and inhibits killing activity of NK cells in endometriosis 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis 2016
- Natural Killer Cells: Key Players in Endometriosis 2015
- KIR2DS5 in the presence of HLA-C C2 protects against endometriosis 2015
- Molecular aspects of development and regulation of endometriosis 2014
- Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia 2014
- Expression of Natural Cytotoxicity Receptors on Peritoneal Fluid Natural Killer Cell and Cytokine Production by Peritoneal Fluid Natural Killer Cell in Women with Endometriosis 2014
- Endometriosis, a disease of the macrophage 2013
- Proangiogenic Tie2+ Macrophages Infiltrate Human and Murine Endometriotic Lesions and Dictate Their Growth in a Mouse Model of the Disease 2011
- Endometriosis and Autoimmunity 2011
- Peripheral biomarkers of endometriosis: a systematic review 2010
- Innate Immune Cells: Gatekeepers of Endometriotic Lesions Growth and Vascularization 2010
- Intraperitoneal immune cell status in infertile women with and without endometriosis 2009
- Faculty Opinions recommendation of Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. 2009
- Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease 2009
- Leukaemia Inhibitory Factor (LIF) Gene Mutations in Women Diagnosed with Unexplained Infertility and Endometriosis Have a Negative Impact on the IVF Outcome A Pilot Study 2009
- Increased frequency of human leukocyte antigen–E inhibitory receptor CD94/NKG2A–expressing peritoneal natural killer cells in patients with endometriosis 2007
- Comparative proteomic analysis of human adenomyosis using two-dimensional gel electrophoresis and mass spectrometry 2007
- Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas 2006
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:23.967219+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK